Ten Eyck R P, Schaerdel A D, Lynett J E, Marks D H, Patrissi G A, Ottinger W E, Stansell M J
J Toxicol Clin Toxicol. 1983;21(3):343-58. doi: 10.3109/15563658308990426.
Effective treatment of cyanide poisoning requires rapid diagnosis, good supportive treatment and the use of a specific antidote. The currently available antidotes offer demonstrated efficacy along with significant potential adverse side effects. We have investigated an alternate approach to antidote therapy for cyanide poisoning by using Stroma-Free Methemoglobin Solution ( SFMS ). Rats injected with an LD100 intravenous dose of cyanide were treated with SFMS equal to 1.5% of their total body hemoglobin. There was a highly significant increase in the survival rate of the treated group compared to saline controls. The potential advantages of SFMS over current antidotes include an immediate onset of action, rapid elimination of cyanide from the body and a mode of action that doesn't compromise any of the patients' oxygen carrying capacity. SFMS shows promise as a significant adjunct in the treatment of cyanide poisoning.
有效治疗氰化物中毒需要快速诊断、良好的支持性治疗以及使用特定解毒剂。目前可用的解毒剂已证明有效,但也有显著的潜在不良副作用。我们研究了一种通过使用无基质高铁血红蛋白溶液(SFMS)治疗氰化物中毒的替代解毒疗法。给大鼠静脉注射致死剂量100%的氰化物后,用相当于其全身血红蛋白1.5%的SFMS进行治疗。与生理盐水对照组相比,治疗组的存活率有显著提高。SFMS相对于目前解毒剂的潜在优势包括作用起效迅速、能快速从体内清除氰化物以及作用方式不会损害患者的任何携氧能力。SFMS有望成为治疗氰化物中毒的重要辅助手段。